Mirae Asset Global Etfs Holdings Ltd. Ventyx Biosciences, Inc. Transaction History
Mirae Asset Global Etfs Holdings Ltd.
- $43.4 Billion
- Q1 2025
A detailed history of Mirae Asset Global Etfs Holdings Ltd. transactions in Ventyx Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Etfs Holdings Ltd. holds 36,438 shares of VTYX stock, worth $81,985. This represents 0.0% of its overall portfolio holdings.
Number of Shares
36,438
Previous 34,878
4.47%
Holding current value
$81,985
Previous $76,000
46.05%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding VTYX
# of Institutions
126Shares Held
45.4MCall Options Held
35.2KPut Options Held
40.6K-
Black Rock Inc. New York, NY4.77MShares$10.7 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct4.23MShares$9.53 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.51MShares$7.9 Million0.0% of portfolio
-
Tang Capital Management LLC San Diego, CA3.1MShares$6.98 Million0.23% of portfolio
-
Sio Capital Management, LLC New York, NY2.58MShares$5.81 Million1.12% of portfolio
About Ventyx Biosciences, Inc.
- Ticker VTYX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 56,527,200
- Market Cap $127M
- Description
- Ventyx Biosciences, Inc., a clinical-stage biopharmaceutical company, develops small molecule product candidates for inflammatory diseases and autoimmune disorders. The company's lead product candidate is VTX958, a tyrosine kinase type 2 inhibitor that is in phase I clinical trials for the treatment of immune-mediated diseases, such as psoriasis...